0.80Open0.80Pre Close0 Volume52 Open Interest25.00Strike Price0.00Turnover158.62%IV47.85%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier22DDays to Expiry0.80Extrinsic Value100Contract SizeAmericanOptions Type0.2381Delta0.0452Gamma21.81Leverage Ratio-0.0479Theta0.0021Rho5.19Eff Leverage0.0134Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet